483 Waterstone Pharmaceuticals Jan 2017

483 Waterstone Pharmaceuticals Jan 2017

Cheryl Clausen FDA$119.00 - Available Now

FDA investigators audited the Waterstone Pharmaceuticals - Tianmen, China facility and issued inspectional observations (via FDA 483) on 20 Jan 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Jan 2017
  • Location: Tianmen, China
  • FEI: 3010777606
Add To Cart